Directory · DE
Biotechnology Research in Germany
A register of firms and the professionals working at them in the Biotechnology Research sector based in Germany. Browse the public index, then filter or export on Kipplo.
Companies
1.1K on file
Emp Biotech Gmbh
emp BIOTECH offers a wide variety of innovative products and services for labeling, purification and modification techniques, including fine chemicals, kits for labeling and purification, coupling reagents, and chemical modification services. At emp Biotech, we challenge ourselves and our colleagues to think outside the box and work smarter. We are a dynamic, highly professional team in a company that’s growing and growing, although we still like to think of ourselves as “a big family”. Come for the science, stay for the great working environment!
51 to 200 staff
Epl Archives
Since 1978, EPL Archives, Inc.(EPL) has established itself as the industry benchmark for the consolidation, preservation, and management of its client’s regulated research and manufacturing material. Today EPL is an international professional services organization that supports the entire regulated product research, development, and commercialization lifecycle targeted to improve the lives of people, plants, and animals. Through its Centers of Excellence, EPL’s experts focus on continuous improvement that advances the art and science of secure material preservation and management. EPL is widely recognized by its clients as a respected partner that consistently delivers high-quality, responsive, compliant and cost effective professional material management services. For more information, please visit our website at or call us at:+1 (703) 435-8780.
51 to 200 staff
Eppendorf
Eppendorf is a leading international life science company that develops, manufactures, and distributes instruments, consumables, and services for use in laboratories around the world. The product portfolio of the business units Liquid Handling & Consumables, Separation & Instrumentation and Bioprocess includes, for example, pipettes, pipette tips, centrifuges, mixers, ultra-freezers and bioreactors for cell and gene research. In addition, Eppendorf offers a wide range of high-quality consumables. In fiscal year 2024, the Eppendorf Group recorded consolidated revenue of €980.3 million and invested €69 million in research and development (R&D). Eppendorf products are used in academic or industrial research laboratories, such as pharmaceutical, biotech, chemical, and food industries, as well as clinical, environmental, forensic, and industrial laboratories for process analysis, production, and quality assurance. Since 1945, the Eppendorf Group has been headquartered in Hamburg, Germany, and today operates production and R&D sites in Europe, Asia and North America and has subsidiaries in more than 30 countries. Today, the Group employs around 4,500 people worldwide. They all act in accordance with the purpose of the company's founders: to improve human living conditions. Imprint: Privacy Statement: https://corporate.eppendorf.com/en/legal-notice-privacy-policy/privacy-statement/
1001 to 5000 staff
Fyonibio Gmbh
FyoniBio supports biotech and biopharma companies in bringing biologics from early development to the clinic. Based in Berlin, we combine biologics development, bioanalytical characterization, and clinical bioanalysis under one roof — offering reliable, transparent, and tailored project support at every stage. With more than 15 years of experience, our team brings together strong scientific expertise and open communication. We focus on what truly matters: understanding each project’s unique challenges and finding practical, science-driven solutions. Our services cover: • Biologics Development – From human and CHO cell line development to upstream and downstream process development, we help produce complex proteins efficiently and ready for scale-up. • Bioanalytical Characterization – Comprehensive analytics including biochemical assays, mass spectrometry, and potency testing. We design, validate, and transfer custom methods that deliver data you can trust. • Clinical Bioanalysis – PK, PD, ADA, and biomarker assay development and validation for protein and oligonucleotide therapeutics, all in line with ICH, FDA, EMA, and GCLP standards. Together with a global network of GMP manufacturing partners, FyoniBio provides a seamless path from concept to clinic — built on expertise, adaptability, and clear communication.
11 to 50 staff
Genexplain
We are the TRANSFAC company, Welcome to geneXplain, home of TRANSFAC®, the essential database for transcription factors. Since 2010 in Germany, we led in bioinformatics, providing top databases & software tools to scientific community. TRANSFAC®: With 35 years of history, TRANSFAC® offers info on TFs, binding sites, regulated genes & interaction partners. Our PWM library is globally renowned for identifying new transcription factor binding sites (TFBSs). HumanPSD™+TRANSPATH®: Complement TRANSFAC® by identifying master regulators in signal transduction networks, providing insights into pathways, gene-disease associations, disease similarity maps & protein-drug interactions. MATCH™ Suite: Automatic pipeline for identifying TFBSs in promoters & enhancers across tissues & processes. geneXplain™ Platform & Genome Enhancer: Software that supports the drug development pipeline, from analyzing high-throughput omics data to identifying master regulatory molecules & potential drug targets.
11 to 50 staff
Hmnc Brain Health
We are a precision medicine pioneer in psychiatry based in Munich. Founded in 2010, our privately held biotech company combines the development of machine learning-enabled companion diagnostics with specific therapeutics to personalize the treatment of neuropsychiatric disorders with a focus on depression. Our ultimate goal is to improve the lives of patients by developing highly disruptive solutions for their high unmet medical needs. We strives to reduce not only the immense individual burden, but also the societal impact of these diseases. We develop patented genetic tests and combines those with innovative exclusively in-licensed medications, resulting in precise therapies for depression and other neuropsychiatric disorders.
11 to 50 staff
Humintech Gmbh
Humintech is a biotech company based in Grevenbroich, Germany. We are primarily focused on the research, development and industrial production of humic matter and humic acids for the agricultural sector. Our products find further use in the feed, pharmaceutical and construction industry, in veterinary medicine and for ecological purposes such as water purification and soil decontamination. Learn more about our company at
11 to 50 staff
Ibl International Gmbh, Tecan Group
IBL International has nearly 30 years experience in development, production and sales of immunodiagnostic products, and is an expert in these fields. Our product portfolio contains enzyme, radio- and luminescence immunoassays that covers over products in a broad range of in-vitro diagnostics for research and routine. These products are designed for manual use, but can be easily adapted for open automated systems. We also have a large selection of “niche products” for special applications to complete our product line. IBL International also focuses on special test systems outside of the standard routine diagnostic tests. For example, we carry immunoassays for the determination of Neurotransmitters or other biogenic amines, steroid hormones in saliva, HMGB1, Neopterin and assays for Alzheimer’s research. We are continuously refining our immunoassays to assure high quality and reliable products. IBL International has a widespread distribution network in over 90 countries. We support our national and international customers with our professional team of product managers and customer service professionals.
51 to 200 staff
Infinite Roots
Infinite Roots® We are Infinite Roots®—a biotech company using fermentation and fungi to create the next generation of sustainable alternative proteins. We believe in a food system that provides accessible, tasty, and nutritious food for everyone while preserving our planet. We are a team of 60 people, from 25 different countries, speaking 15 different languages. To solve global issues, you need minds from around the world! Follow us and watch fungi and food-tech transform the food system!
51 to 200 staff
Inheco
For more than 25 years, Inheco has been developing, manufacturing, and supplying precise lab technology for thermo-mechanical reaction control. The systems integrate seamlessly into automated biochemical workflows, ensuring maximum process stability. With a strong focus on innovation, quality, and service, Inheco enables leading life-science companies to make their research and development processes more efficient, reproducible, and digitally connected.
51 to 200 staff
Invent Diagnostica
We are partner of all diagnostic stakeholders for the procurement of biological material of human origin (e.g. standardisation, innovations, research, development, production, controls.)
51 to 200 staff
Medicover Genetics
Medicover Genetics is a network of laboratories and medical institutions with over two decades of expertise in genetic testing. From our home base in Germany, our team is continuously developing and updating an in-house and tailormade portfolio which is offered internationally in the areas of oncology, rare disease diagnostics, reproductive health, and whole-exome sequencing. Our genetic testing is supported by genetic counselling, to help health care professionals identify the right genetic test for their patients while empowering people to use meaningful genetic tests at the forefront of their diagnostic journey.
201 to 500 staff
Microharvest
MicroHarvest Delivers Better Protein: Sustainable. Nutritious. Scalable. Protein is essential for a healthy diet, but with global demand expected to increase 50% by 2050, current sourcing methods are already harming the planet and often fail to provide truly nutritious food. At MicroHarvest, we are pioneering better protein production through natural fermentation. We produce high-quality protein in just 24 hours—faster than any other method. Like brewing beer or making yogurt, we use microorganisms, nature’s most efficient protein factories, to create tasty, healthy, and sustainable protein at scale. Independent of soil quality or climate, our process runs 24/7 anywhere in the world, requiring only a fraction of the water and land while cutting CO₂ emissions by over 95%. MicroHarvest is addressing today’s demand for highly nutritious food while building a resilient food system for the future. Together, we are HUNGRY FOR THE BETTER. Hamburg & Lisbon Join us, we are hiring!
11 to 50 staff
Seedforward Gmbh
We substitute synthetic agrochemicals with biobased alternatives, emphasizing biobased seed treatments, biostimulants, and biobased plant protection. Our commitment lies in facilitating the transition towards regenerative agriculture. Learn more about our company and explore our products, including MAISGUARD, GRAINGUARD and LEGUGUARD, by visiting Privacy policy: Legal notice:
11 to 50 staff
Tissuse Gmbh
TissUse is a Berlin, Germany-based, biotechnology company, which has developed a unique “Multi-Organ-Chip” platform that provides unparalleled preclinical insight on a systemic level using human tissues. This enabling technology platform consists of a miniaturized construct that closely simulates the activity of multiple human organs in their true physiological context. TissUse’s Multi-Organ-Chips provide a new approach to predict, for example, toxicity, ADME profiles and efficacy in vitro, reducing and replacing laboratory animal testing and streamlining human clinical trials. TissUse’s Multi-Organ-Chips have been utilized in a large variety of applications including drug development, cosmetics, food and nutrition and consumer products since 2012. Imprint: Privacy Policy:
11 to 50 staff
Trenzyme Gmbh
trenzyme GmbH is a privately owned, ISO 9001:2015 certified German Contract Research Organisation (CRO) offering a wide range of highly customized cell culture and recombinant protein production services. Since it's foundation in trenzyme's highly qualified and experienced scientific team has been supporting the research and development departments of academic institutes, biotechnology and pharmaceutical companies around the world as an outsourcing partner. Whether the customer requires high quality services for assay cell line development, GMP production cell lines, cell expansion, stem cell differentiation and characterisation or recombinant protein production & purification, trenzyme offers the ideal solution with a clear mission: Accelerate innovation and save valuable research time & budget! 🧬🧫 🦠 Overview of trenzyme's cell culture and protein services 🦠 🧫🧬 - Manufacturing of customized and standard proteins for diagnostics and research use- Fast delivery of customized microbial and mammalian proteins of choice - Stable GMP-compliant mammalian cell lines and research cell banks - Upstream and downstream process development ready for transfer to contract biological / pharmaceutical manufacturing - Stable cell line development according to your specific needs - Cell-based cardiomyocyte and hepatocyte in vitro toxicity testing and tissue diagnostics - High-throughput protein expression screening and optimization service -> To start solving your challenges and make your research project a success contact our PhD level scientific experts - we are looking forward to supporting you: https://trenzyme.com/contact/-> Quick and easy order of recombinant proteins and cell lines via webshop : https://shop.trenzyme.com/-> Stay informed and up to date with our newsletter https://trenzyme.com/about-us/newsletter/ Imprint: https://trenzyme.com/imprint/ Privacy Policy: https://trenzyme.com/privacy/
11 to 50 staff
Yumab Gmbh
YUMAB Company profile The German biotech company YUMAB was founded in 2012 as spin-off the University of Braunschweig. In little more than five years, YUMAB (a phonetic play on “HUMAB”, which stands for “human monoclonal antibody and in which the “Y” symbolizes the well-known antibody structure) has become a global player in human monoclonal antibody (mAb) development, and drives the general trend in the immunotherapy space toward the use of fully human mAbs for therapeutic applications. The YUMAB® antibody platform provides rapid, reliable and robust development of “state-of-the-art” and “next-generation” fully human antibodies. The technologies base on more than 28 years of continuous research and development of our founders, who are well recognized scientific experts in the field of recombinant antibody technologies and who have an outstanding track-record in academic and industrial research. YUMAB provides optimized antibody development solutions for: i) discovery & development of novel, fully human antibodies, ii) antibody engineering & humanization, and personalized & custom libraries Key features of the YUMAB® platform are: i) world’s best, naturally derived, universal, human antibody libraries (>10e11) ii) powerful in vitro selection technologies including on-cells-selection for difficult targets large scale screening platforms iv) comprehensive portfolio of antibody engineering & humanization technologies v) compatibility to all therapeutic antibody formats YUMAB provides fee for service solutions with attractive pricing and flexible license models & options as well as collaborative projects. YUMAB’s research & development unit performs internal pipeline and partnered projects ranging from the development of novel antibody therapeutics to the discovery to novel targets technologies. Our mission is to make the best human antibody technologies available for the early development to accelerate translation of research from bench to bedsite.
11 to 50 staff
Actome
PICO BioScience advances life science research and drug development through its proprietary Protein Interaction Coupling (PICO) technology. This platform enables high-throughput, absolute quantification of extracellular vesicles (EV), proteins, protein interactions, post-translational modifications with exceptional specificity. Under the Actome trademark, we provide innovative PICO Kits and tailored PICO Services to support diverse research needs, from assay development to advanced proteomic studies. Check out our products in our web shop at https://shop.actome.de or send us your request to info@picobioscience.eu!
1 to 10 staff
Airna
AIRNA, a biotech company pioneering RNA editing therapeutics to restore the health of patients with rare and common diseases. AIRNA’s experienced team is aiming to advance a pipeline of RNA editing therapeutics driven by its powerful and flexible RNA editing platform, RESTORE+.
11 to 50 staff
Amsilk Biogenius Materials
AMSilk's Biogenius Materials made from silk proteins are setting new standards in material innovation. Using cutting-edge science and the most advanced technologies like DNA edition, protein engineering and precision fermentation, we transform biogenic materials inspired by nature into groundbreaking Biongenius Materials. At AMSilk, we turn man-made proteins into formulations, including fibers and yarns, hydrogels and silk powder. The high-performance qualities of our material enable a wide range of applications in the textile, homecare, biomedical, and automobile industries and bring breakthrough benefits for products and customers.
51 to 200 staff
Capricorn Scientific Gmbh
Capricorn Scientific is an ISO-certified German manufacturer of cell culture products such as sera, media, and reagents. We focus on the production of high-quality products for various fields of application in biotechnology, diagnostics, and research. Established in 2016, our headquarters and production facility are located in Ebsdorfergrund, close to the Frankfurt am Main Airport (FRA). This gives us the opportunity to work with different partners and deliver with short lead times, all around the world! As of now, we are proud to offer a product range of over 200 products, either directly to our customers or with the support of our worldwide distribution network. Our new 1,350 m² state-of-the-art production facility, established in 2022, features 350 m² dedicated clean room area and is characterized by spatial separation of products containing animal components and chemically-defined media. While only chemically-defined media are produced in the lower part of the building, the upper production area is used to manufacture cell culture products containing animal components, e.g, fetal bovine serum (FBS), eliminating the risk of cross-contamination for our chemically-defined products. Furthermore, rigorous testing procedures along with comprehensive traceability records and documentation guarantee the excellent and reproducible quality of our products. We are committed to providing high quality, reliability, and the service you have come to expect from a globally active cell culture company. Discover what makes Capricorn Scientific unique and how you can benefit from our knowledge and experience! When partnering with us, you can expect more than just high-quality products. Our young and passionate team of around 65 experts has been working in the field of cell culture for many years and is dedicated to providing you with exceptional service – whenever and wherever you need it. Test our products and find out for yourself!
51 to 200 staff
Cyagen
Cyagen is a global leader in providing comprehensive solutions for both therapeutic target discovery and pre-clinical validation. We offer end-to-end services that empower the entire workflow, from target validation to pre-clinical research. Our core capabilities combine gene-edited models, AI technology, and a wide range of cross-disciplinary CRO services to accelerate your research and development efforts. We leverage cutting-edge platforms, including the HUGO-GT™ Whole Genome Humanized Model and the HUGO-Ab™ mouse, to provide powerful tools for pre-clinical studies. The HUGO-GT™ model is specifically designed to simulate human gene expression, offering a more relevant and predictive platform for drug efficacy and safety testing. Our expertise spans multiple therapeutic areas, with robust CRO services in Neurological Diseases, Oncology, Metabolic Disorders, Ophthalmology, and Autoimmune Diseases. We also utilize our AI-enabled platforms, including the RDDC Rare Disease Database and the AbSeek™ Antibody Computational Platform, to enhance drug discovery. With a global presence and over 18,760 clients in more than 100 countries, Cyagen is dedicated to providing high-efficiency, full-process solutions that help our partners achieve their research goals.
501 to 1000 staff
Friz Biochem Gmbh
Our vision is to make fastest quality diagnostics accessible to anyone, to allow for right treatment at the right time and to provide near patient diagnostics that can be used with as little laboratory equipment and training as possible. With CYCLE® Dx and Lab-direct we have developed two unique patented technology platforms, both enabling for SAFE-molecular diagnostics: Secure = receive reliable results from our certified systems Advanced = get multiple parameters for pathogen testing while using one-step protocols Fast =<30min from sample to result Easy = usable by everyone with no or only little laboratory equipment Thus, our COVID-19 direct RT-PCR kits from the Lab direct series are designed to detect SARS-CoV-2 RNA and COVID-19 mutation(s) in parallel directly from the unprocessed patient sample without any previous additional sample preparation steps, such as RNA extraction. In addition, all COVID-19 direct RT-PCR kits employ a user-friendly one-step protocol from sample to result, significantly reducing handling effort and time. Furthermore, our CYCLE® Dx platform technology provides for multi-parametric, rapid, sensitive and fully automated molecular testing truly at the Point-of-Care. CYCLE® Dx provides the complete diagnostic workflow in a miniaturised environment and transfers Point-of-Care testing to the next level: Gather all information needed in a miniaturised, lab-free environment at highly cost-effective set up. We are based in Neuried, with over 350 qm2 state-of-the-art R&D facilities as well as a sophisticated in-house pilot production-site. Here, our diverse team of highly skilled chemists, biologists and physicists with an extensive experience in molecular diagnostics development is dedicated to constantly provide and further develop our latest technologies.
11 to 50 staff
Jena Bioscience Gmbh
Founded in 1998, Jena Bioscience GmbH is a trusted partner for scientists worldwide, offering innovative solutions in nucleotide chemistry, molecular biology, protein technology and crystallography. As a team of 50+ dedicated experts, we deeply understand the everyday challenges faced in both academic research and biotech environments. That’s why all of our products are designed with scientists’ hearts in mind: high-quality solutions that accelerate discoveries and support science at its basis. Whether it’s a standard reagent or a fully tailored high-end application, we’re here to make your work better with the one ingredient that truly matters: our love for science. We empower your scientific progress by providing the fundamental tools for discovery: the building blocks of life. Follow us for product innovations, scientific updates, and behind-the-scenes perspectives from our team, also on Instagram.
11 to 50 staff
M2p-Labs Gmbh I Microbioreactors I Now Beckman Coulter Life Sciences
m2p-labs is an internationally leading supplier of microbioreactor systems focusing on microreaction and automated solutions for screening and bioprocess development. The product portfolio comprises high-throughput BioLector micro fermentation systems, microtiter FlowerPlates, and automated cultivation RoboLector platforms. Proprietary online monitoring technology increases the number and the information content of microbial experiments, either aerobic, microaerophilic, or strictly anaerobic. Experiments can be conducted with excellent efficiency and high quality at low costs in microscale. The RoboLector enables the automated fermentation of the whole bioprocess, with its specific integration of the BioLector tool into a liquid handling system.
51 to 200 staff
Mikrogen Gmbh
MIKROGEN is a global provider of system solutions for medical laboratory diagnostics. The company´s success factors are the combination of excellent genetic engineering know-how with scientific background and consistent customer orientation. MIKROGEN offers a wide range of system solutions for the indirect detection (antibodies) of pathogens, the direct detection (PCR) of pathogens and the measurement of the pathogen-specific immune status (T-cell assays). The company‘s highly skilled and experienced employees are the key to the success of MIKROGEN. To improve the performance of clinical diagnostics constantly, more than 130 staff members work continuously on the implementation of latest scientific results. Further information can be found at
51 to 200 staff
Mo Re
3D Cell Culture - automated, verified, standardised. At MO:RE, we empower life science researchers to generate reproducible, quality-controlled, and human-relevant 3D cell models (NAM) that accelerate drug discovery, reduce reliance on animals, and prepare R&D pipelines for regulatory approval. The MO:BOT is the first fully automated platform that standardizes NAM workflows from cell culture to drug screening with built-in quality control and regulatory-grade traceability. Every step from organoid generation to downstream assays is tracked, documented, and auditable, creating comprehensive data packages that support IND submissions and establish a foundation for GMP compliance. Unlike fragmented solutions, MO:BOT delivers an integrated system for producing, testing, and validating human-relevant models at scale.
11 to 50 staff
New England Biolabs Gmbh
New England Biolabs GmbH is the NEB service hub for Europe and Africa. We are located at the Technology-Park in Frankfurt-Höchst, enabling us to provide customized service beyond everyday experience. The quality of our personalized services, as well as our ability to deliver high quality products with unsurpassed consistency, guarantee our partners a valuable advantage in their research activities. NEB offers the largest selection of recombinant and native enzymes for genomic research and continues to expand its product offerings into areas related to PCR, gene expression, sample preparation for next generation sequencing, synthetic biology, glycobiology, epigenetics and RNA analysis. Additionally, NEB is focused on strengthening alliances that enable new technologies to reach key market sectors, including the development of molecular diagnostics, as well as nucleic acid vaccines. Imprint: Privacy Policy:
11 to 50 staff
Numaferm
We believe that in the near future peptides have found their way into new markets and are a well-known feed stock for better products in life sciences and beyond. NUMAFERM supports you in these developments – from discovery to commercial production.
11 to 50 staff
T-Knife Therapeutics
T-knife Therapeutics is a biopharmaceutical company dedicated to developing novel therapeutics to fight cancer, initially focused on T cell receptor (TCR) engineered T cell therapies (TCR-Ts), a modality that holds the potential to generate transformative responses in patients with solid tumors. The Company’s unique approach leverages its proprietary HuTCR mouse platform, a next-generation T cell receptor and epitope discovery engine that produces fully human, tumor-specific TCRs, naturally selected in vivo for optimal affinity and high specificity. T-knife is advancing a portfolio of TCR-T product candidates against targets with high unmet medical need, including cancer testis antigens, oncoviral antigens and commonly shared tumor-driving neoantigens. T-knife was founded by leading T-cell and immunology experts using technology developed at the Max Delbruck Center for Molecular Medicine together with Charité – Universitätsmedizin Berlin.
51 to 200 staff
Tubulis Gmbh
Tubulis® generates uniquely matched protein-drug conjugates by combining proprietary novel technologies with disease-specific biology. Our goal is to expand the therapeutic potential of antibody drug conjugates (ADCs) ushering in a new era and delivering better outcomes for patients. We will advance a range of conjugates, unlimited by indication, using our own discovery capabilities and by solving development challenges for partners with both antibody and chemical assets.
51 to 200 staff
Arcensus
Arcensus is an innovative healthcare company dedicated to improving the early diagnosis of genetic conditions. Utilizing our expertise in bioinformatics, we analyze genetic data, extracting meaningful insights that bridge the gap between genes and medicine. Join us on this transformative journey as we integrate genomics into the core of healthcare, shaping the future of medical innovation.
11 to 50 staff
Atem Structural Discovery
ATEM’s vision is to provide our pharmaceutical and biotechnological clients with unprecedented empirical insights into protein structures for successful and accelerated rational drug discovery campaigns. ATEM’s specialised expertise delivers high-resolution cryo electron microscopy (cryo EM) 3D structures of your challenging biological targets. We achieve this by leveraging our unique, completely integrated platform that combines cryo EM optimised biochemical processes with high-end data acquisition hardware and data processing augmented by continuous machine-learning enhancements. Utilising next-gen proprietary software, ATEM delivers more detailed, high-resolution 3D structural models with best-in-class accuracy and faster turnaround times. High-resolution 3D Structural models | Highest accuracy | Faster turnaround times The ATEM cryo EM platform provides unprecedented 3D solutions:* High-resolution 3D structures of difficult to crystallise targets such as large assemblies and membrane proteins * 3D atomic models of ligand-bound targets that allow for extended ligand screening campaigns * Structure determination of high-affinity protein-protein interactions (such as monoclonal antibodies or peptides)* Functional dynamic 3D structural models of the target molecule induced by ligand interactions (small-molecule or biological)* 3D epitope mapping of your target with a palette of mAb/Fab candidates ATEM also provides Analytical EM capabilities:* Rapid transmission electron microscopy (TEM) based insights on protein purification optimisation * Viral vector (i.e. AAV) fill rate analysis with single-particle precision * Morphological characterisations of Lipid Nanoparticle vector systems (i.e. mRNA vaccines) Learn how ATEM can tailor a solution to accelerate your next drug discovery campaign. To find out more about ATEM, visit our website at:
11 to 50 staff
Baseclick
At baseclick GmbH we believe that bioconjugation is not just a method to connect (bio)molecules, but a tool to develop valuable applications. So, a new strategy was needed: click chemistry!" Nobel Prize 2022, the basis of the baseclick patented nucleic acid modification technology". We are a dynamic, highly professional team and enabling life science researchers to overcome challenges and create better solutions in diagnostics, therapeutics, and vaccines development through our proprietary click chemistry. Our mission is to develop and provide the best nucleic acid labeling applications and reagents for the life science market. For further information please visit our website
11 to 50 staff
Bioassay Gmbh
Bioassay GmbH specializes in developing, validating and performing bioanalytical assays in Pharmacology and Toxicology, with particular expertise in potency, safety and other assays under GMP for biopharmaceuticals, including therapeutic antibodies, hormones and cytokines. Bioassay GmbH was privately founded in 2002; we are now a 20+ strong company headquartered in Heidelberg, serving clients in the biotechnology, chemistry and cosmetics sectors. In 2017, we extended our expertise to customized peptide syntheses and peptide-specific antibodies by merging with our Heidelberg Technology Park neighbors, PSL Peptide Specialty Laboratories GmbH (PSL).
11 to 50 staff
Biom Biotech Cluster Development Gmbh
Cluster Management by BioM: Since 1997, Munich’s biotech sector has been supported by BioM Biotech Cluster Development GmbH, a not-for profit service company located in Martinsried in the Southwest of Munich. BioM is sponsored by the Bavarian State Ministry of Economic Affairs and has been commissioned with several tasks and projects which aim to foster Bavaria’s biotechnology sector. BioM offers several services, in particular for small and medium-sized biotech enterprises to help accelerating biomedical innovation. BioM is awarded "Gold Label of Cluster Excellence".
11 to 50 staff
Bioregio Stern Management Gmbh
Seit 2001 ist die BioRegio STERN Management GmbH als Wirtschaftsentwickler für die Life-Sciences tätig. Sie fördert im öffentlichen Auftrag Innovationen, Start-Ups sowie kleine und mittlere Unternehmen. Sie ist eine zentrale Anlaufstelle für Gründer und Unternehmer aus den Bereichen Biotechnologie und Medizintechnik und darüber hinaus auch aus kooperierenden Hightech-Branchen wie Automatisierung und IT. Die BioRegion STERN mit den Regionen Stuttgart und Neckar-Alb und den Städten Tübingen und Reutlingen ist Heimat von über 120 mittelständischen Medizintechnik-Unternehmen. Die Kombination aus etablierten Familienbetrieben, „Hidden Champions“ und über 110 jungen Biotechnologie-Unternehmen ist ein wesentliches Merkmal des Clusters. Ein weiteres herausragendes und zukunftsweisendes Merkmal ist die räumliche Nähe von Unternehmen des ingenieurgetriebenen Mittelstandes und Unternehmen aus der Life-Sciences-Branche. Folgerichtig ist die Strategie der BioRegio STERN Management GmbH, ihr Life-Sciences-Cluster mit der hiesigen Automatisierungstechnik sowie dem Maschinen- und Anlagenbau in Kontakt zu bringen, um eine außergewöhnliche Mischung von Hightech-Kompetenzen aus Start-ups und Weltkonzernen entstehen zu lassen. Die wirtschaftliche Prosperität wird durch wissenschaftliche Exzellenz aus zahlreichen renommierten Forschungsinstituten und drei Universitäten ideal ergänzt. Die BioRegio STERN Management GmbH unterstützt Bestrebungen zur Vermarktung anwendungsnaher Forschung, um innovative Produkte und neue Therapien in den Alltag zu bringen. Deshalb forciert die BioRegio STERN Management GmbH Neugründungen und Kooperationen. Darüber hinaus stellt sie Anträge für Förderprojekte und koordiniert dieselben. Impressum: BioRegio STERN Management GmbH Geschäftsführung: Dr. Klaus Eichenberg (ViSdP) Friedrichstr. 10 70174 Stuttgart T +49 711 870354-0 E info@bioregio-stern.de Aufsichtsratsvorsitz: OB Thomas Keck Amtsgericht Stuttgart HRB 22917 USt-ldNr. DE 218941367
11 to 50 staff
Blink Ag
Home of the BLINK Beads, the BLINK X and the BLINK One. BLINK is revolutionizing the field of bioanalytics and diagnostics. We have created next-generation microfluidics-free digital PCR technology that combines sample nucleic acid extraction, multiplex analysis and quantification in a single compact workflow. Our rapid, ultra-sensitive digital multiplex assays empower scientists and clinicians to make high-impact discoveries and enables rapid molecular diagnostics to achieve an immediate, targeted therapy, ultimately leading to better patient outcomes and a more effective healthcare system.
51 to 200 staff
Cambrium
Cambrium's mission is to trigger the next wave of material innovation by harnessing biology’s molecular building blocks. We fundamentally believe that the ability to align economic and environmental incentives makes biology the most important manufacturing technology of the 21st century. Using our molecular design technology, we create novel material building blocks with previously inaccessible functionalities. Our molecules enable innovators to create products that are better for people, and the planet. We are a highly interdisciplinary team of scientists, engineers, designers and entrepreneurs, united by our vision to create materials that matter. Intrepid, vibrant, and purpose-driven we are on a quest to unlock the power of biology, and reinvent materials from the molecular level.
11 to 50 staff
Fiz Frankfurt Biotechnology Innovation Center
FiZ – New. German Engineering. As a market-oriented technology center, the FiZ Frankfurt Biotechnology Innovation Center offers small- and medium-sized companies in the life science sector a unique basis for innovation and growth – on two levels: Customized infrastructure for 19 tenant companies with access to collaborations, interdisciplinary networks and markets FiZ Synergy Projects / Start-ups in cooperation with the FiZ Management. Our Target Market: solutions for personalized health care
1 to 10 staff
Fraunhofer Izi
The Fraunhofer Institute for Cell Therapy and Immunology IZI investigates and develops specific problem solutions at the interfaces of medicine, life sciences and engineering. The Institute practices contract research for biotechnological, pharmaceutical and medical-technological companies, hospitals, diagnostic laboratories and research facilities. Within the Business Units of Agents, Cell Therapy, Diagnostic and Biobanking, the Institute develops, optimizes and validates methods, materials and products. The Institute's core competencies are located in the field of Regenerative Medicine, in particular in the indication areas of oncology, ischemia and autoimmune, inflammatory and infectious diseases. The Institute is clinically oriented and conducts quality checks and the GMP-compliant manufacture of investigational medicinal products. Moreover, the Institute provides support in obtaining manufacturing authorizations and approvals.
501 to 1000 staff
Frings
As a technology specialist for fermentation and bioprocesses, Frings is your partner for plant engineering and manufacturing from laboratory to industrial scale. Bioreactor systems matching special customer requirements are our core competence and key technology. In addition, we also offer high-quality modular subsystems, components or equipment for different up- and downstream processes including the corresponding automation technology. We can take your laboratory findings and transfer these into industrial processes on different scales as required. Trials in our own laboratory devices and pilot units provide a solid basis for detailed design as well as for feasibility and profitability studies.
51 to 200 staff
Hiss Diagnostics Gmbh
HiSS Diagnostics GmbH ist seit über 35 Jahren zuverlässiger Anbieter von Produkten für die Labordiagnostik von renommierten Herstellern. Zu unseren Kunden gehören Universitäten, Forschungseinrichtungen und Unternehmen der Pharma- und Biotech-Branche, welche von uns deutschlandweit versorgt werden. ISO 13485 zertifiziert
11 to 50 staff
Indivumed Services
Crown Bioscience, a global contract research organization (CRO) headquartered in the United States and a part of JSR Life Sciences and Japan-based JSR Corporation, today announces the complete integration of Indivumed Services. This strategic move, following the acquisition in 2023, solidifies Crown Bioscience's standing in oncology drug research and development. As a result of this merger, the Indivumed Services brand will be fully retired in February 2025.
51 to 200 staff
Invitek Diagnostics
Invitek Diagnostics is a global provider of molecular diagnostics products that cover the full spectrum of workflows, from sample to result. Get ready to simplify your workflows and enjoy streamlined processes. Invitek products are designed for ultimate ease of use and time saving, with a modular system that can be adapted to any laboratory environment. With Invitek Diagnostics, you can streamline your processes and work efficiently from sample collection and extraction to detection and point-of-use. Our new modular product approach ensures that our customers have everything they need to deliver efficient, accurate results with minimal effort. You can expect to receive products that are both reliable and user-friendly, along with our top-notch customer service.
11 to 50 staff
Pan-Biotech Gmbh
Since 1988 PAN-Biotech demonstrated its strength with innovative, first-class quality products and excellent services for cell culture around the globe. Specialized in the manufacture and distribution of cell culture products like sera, media, serum-free systems, reagents, biologicals and more we deliver our goods to customers from research, clinics and the biopharmaceutical industry. Our highly skilled team with operating experience in various fields of cell technology guarantees product development based on the needs and requirements of our customers. Individual wishes are always welcome. Production takes place in Germany, Aidenbach, Bavaria: Quality "Made in Germany"!
51 to 200 staff
Pelobiotech Gmbh
PELOBiotech GmbH - your premium choice for human and animal primary cells, stem cells, and cell culture media and tools. We distribute a broad range of cell culture products (in GMP or RuO quality) from exclusive worldwide partners. More specifically we carry the following: • Human and animal primary, stem, and iPS-derived cells and media • 2D and 3D cell culture tools • Tissue dissociation enzymes, sample preparation, and purification tools • Cell-based assays We aim to provide the highest quality cell culture products at reasonable prices. Please reach out today and let us show you how we can help your in vitro research excel. Managing directors: Dr. Lothar Steeb and Dr. Peter Frost Trade register: Amtsgericht München HRB 197203 UID-Nr: DE282095341 EORI-Nr: DE513247033551940
11 to 50 staff
Planet A Foods
Imagine a world without chocolate. Horrifying, right? But the supply of cocoa is endangered and chocolate is as bad as meat for our planet. We make future-proof chocolate using precision fermentation. Doing this, our chocolate is 10x more sustainable and 20% cheaper than conventional chocolate. In order to mimic the organoleptic properties of chocolate (tender, smoothly melting taste release) we are working on the flavor itself but also on replacing the cocoa butter. 55 Mio lbs of chocolate are consumed every day. By 2035 we will substitute a big chunk of it through our sustainable chocolate.
11 to 50 staff
